Review



human pcsk9 catalog  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    R&D Systems human pcsk9 catalog
    Baseline characteristics of patients before the initiation of <t> PCSK9 </t> mAb <xref ref-type= a ." width="250" height="auto" />
    Human Pcsk9 Catalog, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 120 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human pcsk9 catalog/product/R&D Systems
    Average 94 stars, based on 120 article reviews
    human pcsk9 catalog - by Bioz Stars, 2026-03
    94/100 stars

    Images

    1) Product Images from "Circulating Endothelial Progenitor Cells in Patients with Established Cardiovascular Disease Treated with PCSK9 Monoclonal Antibodies "

    Article Title: Circulating Endothelial Progenitor Cells in Patients with Established Cardiovascular Disease Treated with PCSK9 Monoclonal Antibodies

    Journal: American Journal of Preventive Cardiology

    doi: 10.1016/j.ajpc.2024.100896

    Baseline characteristics of patients before the initiation of  PCSK9  mAb <xref ref-type= a ." title="Baseline characteristics of patients before the initiation of PCSK9 mAb a ..." property="contentUrl" width="100%" height="100%"/>
    Figure Legend Snippet: Baseline characteristics of patients before the initiation of PCSK9 mAb a .

    Techniques Used: Medications

    Lipids profile of study patients before and after initiation of  PCSK9  mAb <xref ref-type= a ." title="... of study patients before and after initiation of PCSK9 mAb a ..." property="contentUrl" width="100%" height="100%"/>
    Figure Legend Snippet: Lipids profile of study patients before and after initiation of PCSK9 mAb a .

    Techniques Used:

    cEPCs levels before and following the initiation of PCSK9 mAb. Percentage levels of (A) CD34 (+) /VEGFR-2 (+) and (B) CD133 (+) /VEGFR-2 (+) cells at 1 month and 3 months following the initiation of PCSK9 mAb.
    Figure Legend Snippet: cEPCs levels before and following the initiation of PCSK9 mAb. Percentage levels of (A) CD34 (+) /VEGFR-2 (+) and (B) CD133 (+) /VEGFR-2 (+) cells at 1 month and 3 months following the initiation of PCSK9 mAb.

    Techniques Used:

    CFUs and MTT assay levels before and following the initiation of PCSK9 mAb. Number of EPCs-CFUs (left) and MTT assay (right) performed before and after 1-month and 3-months of treatment with PCSK9 mAb.
    Figure Legend Snippet: CFUs and MTT assay levels before and following the initiation of PCSK9 mAb. Number of EPCs-CFUs (left) and MTT assay (right) performed before and after 1-month and 3-months of treatment with PCSK9 mAb.

    Techniques Used: MTT Assay

    cEPCs levels and function, at time 0, 1 month and 3 months following the initiation of  PCSK9  mAb.
    Figure Legend Snippet: cEPCs levels and function, at time 0, 1 month and 3 months following the initiation of PCSK9 mAb.

    Techniques Used:



    Similar Products

    94
    R&D Systems human pcsk9 catalog
    Baseline characteristics of patients before the initiation of <t> PCSK9 </t> mAb <xref ref-type= a ." width="250" height="auto" />
    Human Pcsk9 Catalog, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human pcsk9 catalog/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    human pcsk9 catalog - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    94
    R&D Systems catalog number dcrp00
    Baseline characteristics of patients before the initiation of <t> PCSK9 </t> mAb <xref ref-type= a ." width="250" height="auto" />
    Catalog Number Dcrp00, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/catalog number dcrp00/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    catalog number dcrp00 - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    93
    R&D Systems serum catalog numbers dr2a00 sr2a00 pdr2a00
    Baseline characteristics of patients before the initiation of <t> PCSK9 </t> mAb <xref ref-type= a ." width="250" height="auto" />
    Serum Catalog Numbers Dr2a00 Sr2a00 Pdr2a00, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/serum catalog numbers dr2a00 sr2a00 pdr2a00/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    serum catalog numbers dr2a00 sr2a00 pdr2a00 - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    R&D Systems catalog no dpsg10
    Baseline characteristics of patients before the initiation of <t> PCSK9 </t> mAb <xref ref-type= a ." width="250" height="auto" />
    Catalog No Dpsg10, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/catalog no dpsg10/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    catalog no dpsg10 - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    R&D Systems catalog no dad120
    Baseline characteristics of patients before the initiation of <t> PCSK9 </t> mAb <xref ref-type= a ." width="250" height="auto" />
    Catalog No Dad120, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/catalog no dad120/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    catalog no dad120 - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    R&D Systems catalog no dppa00
    Baseline characteristics of patients before the initiation of <t> PCSK9 </t> mAb <xref ref-type= a ." width="250" height="auto" />
    Catalog No Dppa00, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/catalog no dppa00/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    catalog no dppa00 - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    R&D Systems human trail tnfsf10 quantikine elisa kit catalog
    Baseline characteristics of patients before the initiation of <t> PCSK9 </t> mAb <xref ref-type= a ." width="250" height="auto" />
    Human Trail Tnfsf10 Quantikine Elisa Kit Catalog, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human trail tnfsf10 quantikine elisa kit catalog/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    human trail tnfsf10 quantikine elisa kit catalog - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    94
    R&D Systems human cxcl10 ip 10 quantikine elisa kit catalog
    Baseline characteristics of patients before the initiation of <t> PCSK9 </t> mAb <xref ref-type= a ." width="250" height="auto" />
    Human Cxcl10 Ip 10 Quantikine Elisa Kit Catalog, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human cxcl10 ip 10 quantikine elisa kit catalog/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    human cxcl10 ip 10 quantikine elisa kit catalog - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    90
    R&D Systems quantikine elisa mouse adiponectin/acrp30 (catalog: mrp30)
    Baseline characteristics of patients before the initiation of <t> PCSK9 </t> mAb <xref ref-type= a ." width="250" height="auto" />
    Quantikine Elisa Mouse Adiponectin/Acrp30 (Catalog: Mrp30), supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/quantikine elisa mouse adiponectin/acrp30 (catalog: mrp30)/product/R&D Systems
    Average 90 stars, based on 1 article reviews
    quantikine elisa mouse adiponectin/acrp30 (catalog: mrp30) - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    Baseline characteristics of patients before the initiation of  PCSK9  mAb <xref ref-type= a ." width="100%" height="100%">

    Journal: American Journal of Preventive Cardiology

    Article Title: Circulating Endothelial Progenitor Cells in Patients with Established Cardiovascular Disease Treated with PCSK9 Monoclonal Antibodies

    doi: 10.1016/j.ajpc.2024.100896

    Figure Lengend Snippet: Baseline characteristics of patients before the initiation of PCSK9 mAb a .

    Article Snippet: Levels of PCSK9 were measured using ELISA assays according to the manufacturer's recommendations (Human PCSK9 catalog number: DPC900 SPC900 PDPC900, R&D systems).

    Techniques: Medications

    Lipids profile of study patients before and after initiation of  PCSK9  mAb <xref ref-type= a ." width="100%" height="100%">

    Journal: American Journal of Preventive Cardiology

    Article Title: Circulating Endothelial Progenitor Cells in Patients with Established Cardiovascular Disease Treated with PCSK9 Monoclonal Antibodies

    doi: 10.1016/j.ajpc.2024.100896

    Figure Lengend Snippet: Lipids profile of study patients before and after initiation of PCSK9 mAb a .

    Article Snippet: Levels of PCSK9 were measured using ELISA assays according to the manufacturer's recommendations (Human PCSK9 catalog number: DPC900 SPC900 PDPC900, R&D systems).

    Techniques:

    cEPCs levels before and following the initiation of PCSK9 mAb. Percentage levels of (A) CD34 (+) /VEGFR-2 (+) and (B) CD133 (+) /VEGFR-2 (+) cells at 1 month and 3 months following the initiation of PCSK9 mAb.

    Journal: American Journal of Preventive Cardiology

    Article Title: Circulating Endothelial Progenitor Cells in Patients with Established Cardiovascular Disease Treated with PCSK9 Monoclonal Antibodies

    doi: 10.1016/j.ajpc.2024.100896

    Figure Lengend Snippet: cEPCs levels before and following the initiation of PCSK9 mAb. Percentage levels of (A) CD34 (+) /VEGFR-2 (+) and (B) CD133 (+) /VEGFR-2 (+) cells at 1 month and 3 months following the initiation of PCSK9 mAb.

    Article Snippet: Levels of PCSK9 were measured using ELISA assays according to the manufacturer's recommendations (Human PCSK9 catalog number: DPC900 SPC900 PDPC900, R&D systems).

    Techniques:

    CFUs and MTT assay levels before and following the initiation of PCSK9 mAb. Number of EPCs-CFUs (left) and MTT assay (right) performed before and after 1-month and 3-months of treatment with PCSK9 mAb.

    Journal: American Journal of Preventive Cardiology

    Article Title: Circulating Endothelial Progenitor Cells in Patients with Established Cardiovascular Disease Treated with PCSK9 Monoclonal Antibodies

    doi: 10.1016/j.ajpc.2024.100896

    Figure Lengend Snippet: CFUs and MTT assay levels before and following the initiation of PCSK9 mAb. Number of EPCs-CFUs (left) and MTT assay (right) performed before and after 1-month and 3-months of treatment with PCSK9 mAb.

    Article Snippet: Levels of PCSK9 were measured using ELISA assays according to the manufacturer's recommendations (Human PCSK9 catalog number: DPC900 SPC900 PDPC900, R&D systems).

    Techniques: MTT Assay

    cEPCs levels and function, at time 0, 1 month and 3 months following the initiation of  PCSK9  mAb.

    Journal: American Journal of Preventive Cardiology

    Article Title: Circulating Endothelial Progenitor Cells in Patients with Established Cardiovascular Disease Treated with PCSK9 Monoclonal Antibodies

    doi: 10.1016/j.ajpc.2024.100896

    Figure Lengend Snippet: cEPCs levels and function, at time 0, 1 month and 3 months following the initiation of PCSK9 mAb.

    Article Snippet: Levels of PCSK9 were measured using ELISA assays according to the manufacturer's recommendations (Human PCSK9 catalog number: DPC900 SPC900 PDPC900, R&D systems).

    Techniques: